Surien Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.16 Cr
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 20.21 Cr
- Satisfied Charges ₹ 6.06 Cr
- Revenue Growth -38.04%
- Profit Growth 83.66%
- Ebitda 41.33%
- Net Worth 2.24%
- Total Assets -7.44%
About Surien Pharmaceuticals
Surien Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 19 April 2004 and has a history of 20 years and 11 months. Its registered office is in Chennai, Tamil Nadu.
The Corporate was formerly known as Shince Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.16 Cr.
The company currently has active open charges totaling ₹20.21 Cr. The company has closed loans amounting to ₹6.06 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramasamy Krishnamoorthy, Gowri Krishnamoorthy, and Chathurappan Anbazhagan serve as directors at the Company.
Company Details
- Location Chennai, Tamil Nadu
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TN2004PTC053031
- Company No.
053031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Who are the key members and board of directors at Surien Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramasamy Krishnamoorthy  | Managing Director | 21-Apr-2007 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gowri Krishnamoorthy | Director | 21-Apr-2004 | Current |
| Chathurappan Anbazhagan | Whole-Time Director | 11-Oct-2018 | Current |
Financial Performance of Surien Pharmaceuticals.
Surien Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 38.04% decrease. The company also saw a substantial improvement in profitability, with a 83.66% increase in profit. The company's net worth moved up by a moderate rise of 2.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surien Pharmaceuticals?
Unlock access to Surien Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sonivar Pharma Private Limited
Ramasamy Krishnamoorthy and Gowri Krishnamoorthy are mutual person
- Shince Pharmaceuticals Private Limited
Ramasamy Krishnamoorthy and Gowri Krishnamoorthy are mutual person
- Chennai Jk Studio Technologies Private Limited
Ramasamy Krishnamoorthy and Gowri Krishnamoorthy are mutual person
Charges (Loans)
Open Charges
₹20.21 Cr
Satisfied Charges
₹6.06 Cr
Charges Breakdown by Lending Institutions
- Others : 11.29 Cr
- State Bank Of India : 8.92 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Dec 2023 | Others | ₹5.20 M | Open |
| 22 Sep 2022 | Others | ₹10.77 Cr | Open |
| 04 Sep 2010 | State Bank Of India | ₹8.92 Cr | Open |
| 31 Oct 2016 | Others | ₹1.00 Cr | Satisfied |
| 10 Jan 2009 | Karnataka Bank Limited | ₹1.00 Cr | Satisfied |
How Many Employees Work at Surien Pharmaceuticals?
Unlock and access historical data on people associated with Surien Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surien Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surien Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Surien Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Surien Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Surien Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
- Charges
A charge with Others amounted to Rs. 0.52 Cr with Charge ID 100828083 was registered on 02 Dec 2023.
- Charges
A charge with Others amounted to Rs. 10.77 Cr with Charge ID 100615448 was registered on 22 Sep 2022.
- Charges
A charge with State Bank Of India of Rs. 8.92 Cr registered on 04 Sep 2010 with Charge ID 10294826 was modified on 31 Dec 2021.
- Director Appointment
Chathurappan Anbazhagan was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 11 Oct 2018 & has been associated with this company since 6 years 5 months .
Frequently asked questions
What is the Incorporation or founding date of Surien Pharmaceuticals Private Limited?
Surien Pharmaceuticals Private Limited was incorporated on 19 Apr 2004.
What is authorized share capital and paid-up capital of Surien Pharmaceuticals Private Limited?
The authorized share capital of Surien Pharmaceuticals Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 2.16 Cr.
Who are the current board members & directors of Surien Pharmaceuticals Private Limited?
Currently 3 directors are associated with Surien Pharmaceuticals Private Limited.
- Ramasamy Krishnamoorthy
- Gowri Krishnamoorthy
- Chathurappan Anbazhagan
What is the registered address of Surien Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Surien Pharmaceuticals Private Limited is 108 Chekkadi Street, Kovur India, Chennai, Tamil Nadu, 602101.
What is the corporate identification number (CIN) and company number of Surien Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Surien Pharmaceuticals Private Limited is U24232TN2004PTC053031 and the company number is 053031 as per Ministry of Corporate Affairs (MCA).
What is the official website of Surien Pharmaceuticals Private Limited?
The Official website of Surien Pharmaceuticals Private Limited is https://www.surienpharmaceuticals.com
What has been the recent revenue trend for Surien Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Surien Pharmaceuticals Private Limited has fallen by -38.04%.
What change has been observed in the net worth of Surien Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Surien Pharmaceuticals Private Limited has experienced an upsurge of 2.24%.
What are the total open charges for Surien Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Surien Pharmaceuticals Private Limited amount to ₹ 20.21 Cr.
When was the last Balance Sheet of Surien Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Surien Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.